Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We compared the influences of pretreatment with the narcotic antagonist drug naloxone and the neuropeptide L-prolyl-L-leucyl-glycinamide (PLG) upon apomorphine-induced stereotypic climbing activity in mice and apomorphine-induced contralateral rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
Naloxone
produced dose-related potentiation in the mouse climbing model, while PLG was without effect. On the other hand, PLG produced dose-related potentiation in the rat rotational paradigm, while naloxone was without appreciable influence. These findings show an
asymmetrical
potentiation of apomorphine by naloxone and PLG in these two standard experimental models of striatal dopaminergic activity.
...
PMID:Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide. 613 36
Morphine antagonized d-amphetamine circling in rats which had received unilateral 6-OHDA lesions of the striatum but failed to reduce the circling in rats with both a unilateral 6-OHDA striatal lesion and a raphe (5-HT) lesion.
Naloxone
precipitated withdrawal of morphine tolerant rats greatly enhanced d-amphetamine circling when the rats had a 6-OHDA lesion but not when both 6-OHDA and raphe lesions were present. It is concluded that 5-HT is necessary for the morphine-induced inhibition of the circling. The effect of morphine tolerance and naloxone precipitated withdrawal on brain 5-HT function was investigated using a putative 5-HT rotation model in which both a dopamine and a 5-HT agonist were administered to rats with an
asymmetrical
medial raphe lesion. The findings suggest that chronic treatment with morphine increases striatal 5-HT function.
...
PMID:Effect of morphine on circling behaviour in rats with 6-hydroxydopamine striatal lesions and electrolesions of the raphe nucleus. 719 77